Phentolamine
| Clinical data | |
|---|---|
| Trade names | Regitine, Oraverse, Ryzumvi |
| AHFS/Drugs.com | Monograph |
| Routes of administration | intravenous, intramuscular, eye drops |
| ATC code | |
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Metabolism | Liver |
| Elimination half-life | 19 minutes |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| IUPHAR/BPS | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.000.049 |
| Chemical and physical data | |
| Formula | C17H19N3O |
| Molar mass | 281.359 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (what is this?) (verify) | |
Phentolamine, sold under the brand name Regitine among others, is a reversible nonselective α-adrenergic antagonist.